Enhertu

Free

Name: ENHERTU
Generic Name: Trastuzumab Deruxtecan
Dosage Form & Strength: For injection: 100 mg lyophilized powder in a single-dose vial
Manufactured: Daiichi Sankyo, Inc.

Category: Innovator Products Brand: Astrazeneca

Description
Reviews (0)

Description

Enhertu is a HER2-directed antibody and topoisomerase inhibitor conjugate indicated for the treatment of:

adult patients with unresectable or metastatic HER2-positive breast cancer
adult patients with unresectable or metastatic non-small cell lung cancer (NSCLC)
adult patients with locally advanced or metastatic HER2-positive gastric or gastroesophageal junction adenocarcinoma

Note: Enhertu (Trastuzumab Deruxtecan) is an FDA approved medicine.